Channelling RNA interference to cure disease. Providing the tools for precision medicine.

Our programmes

Our upgraded, patient-friendly delivery technology is suitable for applications in a variety of disease settings. Our liver centric pipeline is currently build around three main areas of high unmet need: haematology, metabolic and rare diseases.

our-programmes-light@2x.png our-programmes-mobile-light@2x.png

Out-licensed programmes

We have out-licensed our siRNA stabilisation chemistry technology (AtuRNAiTM) to Quark Pharmaceuticals, who have progressed drug candidates that use this technology in late-stage clinical trials.

_Outlicenced_Desktop_LightBackground.png _Outlicenced_Mobile_LightBackground.png

Please click the licensee programme names below to view our factsheets.

  • pipeline-logo1.png
  • pipeline-logo2.png